SCHEMBL13725249

SCHEMBL13725249

O=C(Nc1ccccc1)c1cccc2c1NC(C(=O)O)C1CC=CC21

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDC25B P30305 1/20 0.73
▸ PTPN7 P35236 13/20 0.70
▸ HSPA1A P0DMV8 9/20 0.70
▸ HSPA8 P11142 6/20 0.70
▸ CD44 P16070 1/20 0.70
▸ MSN P26038 1/20 0.70
▸ GAPDH P04406 5/20 0.64
▸ TDP1 Q9NUW8 5/20 0.64
▸ KDM4E B2RXH2 4/20 0.64
▸ MEN1 O00255 4/20 0.64
▸ POLB P06746 4/20 0.64
▸ MAPT P10636 4/20 0.64
▸ KMT2A Q03164 4/20 0.64
▸ HSD17B10 Q99714 4/20 0.64
▸ L3MBTL1 Q9Y468 4/20 0.64
▸ RECQL P46063 3/20 0.64
▸ BLM P54132 3/20 0.64
▸ THRB P10828 2/20 0.64
▸ CACNA1B Q00975 2/20 0.64
▸ APBA1 Q02410 2/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13724764 0.94 PTPN7 (0.69) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13725577 0.92 CDC25B (0.67) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13725582 0.89 CDC25B (0.64) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13725604 0.86 PTPN7 (0.65) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13725131 0.86 CDC25B (0.54) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13749738 0.85 CDC25B (0.52) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL14758490 0.85 CDC25B (1.00) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL2804418 0.85 CDC25B (1.00) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13725259 0.83 CDC25B (0.53) CDC25BPTPN7HSPA1AHSPA8CD44
SCHEMBL13726071 0.82 PTPN7 (1.00) CDC25BPTPN7HSPA1AHSPA8CD44

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA INC. (US) 2009-08-13 — — US disclosed
WO-2009073550-A2 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS MAXTHERA, INC. (US) 2009-06-11 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203726-A1 SUBSTITUTED TETRAHYDROQUINOLINES AS ANTIBACTERIAL AGENTS NISCH, NDUFS3, SDHA CDC25B 1626/4885PTPN7 3898/4885HSPA1A 581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback